HLA class II-mediated death is induced via fas/fas ligand interactions in human splenic B lymphocytes

Blood

Volumn 89, Issue 6, 1997, Pages 1996-2007

  Truman, Jean Philip ^b   Choqueux, Christine ^b   Tschopp, Jürg ^b   Vedrenne, Jocelyn ^b   Le Deist, Françoise ^b   Charron, Dominique ^b   Mooney, Nuala ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; HLA ANTIGEN CLASS 2; LIGAND; MEMBRANE PROTEIN;

ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; ETIOLOGY; HUMAN; HUMAN CELL; LIGAND BINDING; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0030968523     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.6.1996     Document Type: Article

References (56)

1. Sin Y, Szalay MG, Paskar L, Boyer M, Singh B, Green DR: Activation-induced cell death in T cell hybridomas is due to apoptosis. J Immunol 44:3326, 1990
2. Ishigami T, Kim K-M, Horiguchi Y, Higaki Y, Hata D, Heike T, Katamura K, Mayumi M, Mikawa H: Anti-IgM antibody-induced cell death in a human B lymphoma cell line, B104, represents a novel programmed cell death. J lmmunol 148:360, 1992
3. Russell JH, Rush B, Weaver C, Wang R: Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 90:4409, 1993
4. Watanabe-Fukunage R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314, 1992
5. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969, 1994
6. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IAG, Debatin KM, Fischer A, de Villartay JP; Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1342,1995
7. Fisher GM, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935, 1995
8. Doyle C, Strominger JL: lnteraction between CD4 and class II MHC molecules mediates cell adhesion. Nature 330:256, 1987
9. Fraser JD: High-affinity binding of staphylpeoccal enterotoxins A and B to HLA-DR. Nature 339:221, 1989
10. Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC: Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33, 1993
11. Schafer PH, Pierce SK: Evidence for dimers of MHC class II molecules in B lymphocytes and their role in low affinity T cell responses. Immunity 1:699, 1994
12. Roucard C, Garban F, Mooney NA, Charron DJ, Ericson ML: Conformation of HLA class II molecules: Evidence for superdimers and empty molecules on human antigen presenting cells. J Biol Chem 274:12,993, 1996
13. Garban F, Ericson M, Roucard C, Rabian-Herzog C, Teisserenc H, Sauvanet E, Charron D, Mooney N : Detection of empty HLA class II molecules on cord blood B cells. Blood 87:3970, 1996
14. Fuleihan R, Mourad W, Geha RS, Chatila T: Engagement of MHC-class II molecules by staphylococcal exotoxins delivers a comitogenic signal to human B cells. J Immunol 146:1661, 1991
15. Mourad W, Geha RS, Chatila T: Engagement of major histocompatibility complex class II molecules induces sustained lymphocyte function associated molecule 1 dependent cell adhesion. J Exp Med 172:1513, 1990
16. Mooney NA, Ju L, Brick-Ghannam C, Charron DJ: Bacterial superantigen signaling via HLA class II on human B lymphocytes. Mol Immunol 31:675, 1994
17. Lane PJL, McConnell FM, Schieven GL, Clark EA, Ledbetter JA: The role of class II molecules in human B cell activation. J Immunol 144:3684, 1990
18. Mooney NA, Grillot-Courvalin C, Hivroz C, Ju LY, Charron D: Early biochemical events after MHC class II-mediated signaling on human B lymphocytes. J Immunol 145:2070, 1990
19. Truman J-P, Ericson ML, Choqueux-Séébold CJM, Charron DJ, Mooney NA: Lymphocyte programmed cell death is mediated via HLA class II DR. Int Immunol 6:887, 1994
20. Yoshino T, Cao L, Nishiuchi R, Yamadori I, Kondo E, Teramoto N, Hayashi K, Takahashi K, Kamikawaji N, Akagi T: Ligation of HLA class II molecules promotes sensitivity to CD95 (Fas antigen. APO-1)-mediated apoptosis. Eur J Immunol 25:2190, 1995
21. Smith CA, Farrah T, Goodwin RG: The TNF receptor super-family of cellular and viral proteins: Activation, costimulation, and death. Cell 76:959, 1994
22. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
23. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169, 1993
24. Yonehara S, Ishii A, Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747, 1989
25. Trauth BC, Klas C, Peters AMJ, Matku A, Möller P, Falk W, Debatin K-M, Krammer P-H: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301, 1989
26. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ogna S, Hatake K, Drummond A, Nagata S: Fas ligand in human serum. Nat Med 2:317, 1996
27. Nagata S, Golstein P: The Fas death factor. Science 267:1449, 1995
28. 2+-independent T cell-mediated cytotoxicity. J Exp Med 177:195, 1993
29. Matsumoto K, Yoshikai Y, Asano T, Himeno K, Iwasaki A, Nomoto K: Defect in negative selection in lpr donor-derived T cells differentiating in non-lpr host thymus. J Exp Med 173:127, 1991
30. Herron LR, Eisenberg RA, Roper E, Kakkanaiah VN, Cohen PL, Kotzin BL: Selection of the T cell receptor repertoire in lpr mice. J Immunol 151:3450, 1993
31. Sidman CL, Marshall JD, von Boehmer H: Transgenic T cell repertoire interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice. Eur J Immunol 22:499, 1992
32. Alderson MR, Armitage RJ, Maraskovsky E, Tough TW, Roux E, Schooley K, Ramsdall F, Lynch DH: Fas transduces activation signals in normal human T lymphocytes. J Exp Med 178:2231, 1993
33. Daniel PT, Krammer PH: Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J Immunol 152:5624, 1994
34. Klas C, Debatin K-M, Jonker RR, Krammer PH: Activation interferes with the APO-1 pathway in mature human T cells. Int Immunol 5:625, 1993
35. Peter ME, Kishkel FC, Hellbardt S, Chinnaiyan AM, Krammer PH, Dixit V. CD95 (APO-1, Fas)-associating signalling proteins. Cell Death Differ 3:161, 1996
36. Dhein J, Walczak H, Bäumler C, Debatin K-M, Krammer PH: Autocrine T-cell suicide mediated by Apo-1 (Fas/CD95). Nature 373:438, 1995
37. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441, 1995
38. Ju S-T, Panka DJ, Cui H, Ettinger R, El-Khatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A: Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444, 1995
39. Tanaka M, Suda T, Takahashi T, Nagata S: Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J 14:1129, 1995
40. Renno T, Hahne M, MacDonald HR: Proliferation is a prerequisite for bacterial superantigen induced T cell apoptosis in vivo. J Exp Med 181:2283, 1995
41. Hahne M, Peitsch MC, Irmler M, Schröter M, Lowin B, Rousseau M, Bron C, Renno T, French L, Tschopp J: Characterization of the non-functional Fas ligand of gld mice. Int Immunol 7:1381, 1995
42. Lowin B, Mattman C, Hahne M, Tschopp J: Comparison of Fas (Apo-1/CD95)-and perforin-mediated cytotoxicity in primary T lymphocytes. Int Immunol 8:57, 1996
43. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271, 1991
44. Owens GP, Hahne WE, Cohen JJ: Identification of mRNAs associated with programmed cell death in immature thymocytes. Mol Cell Biol 11:4177, 1991
45. Suda T, Okazaki T, Naito Y, Yokota T, Avai N, Ozaki S, Nakao K, Nagata S: Expression of the Fas ligand in cells of the T cell lineage. J Immunol 154:3806, 1995
46. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, Runkel L: Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182:1223, 1996
47. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189, 1995
48. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC: A role for CD95 ligand in preventing graft rejection. Nature 377:630, 1995
49. Süss G, Shortrnan K: A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand-induced apoptosis. J Exp Med 183:1789, 1996
50. O'Connell J, O'Sullivan GC, Collins JK, Shanahan F: The Fas counterattack: Fas mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med 184:1075, 1996
51. Peter ME, Dhein J, Ehret A, Hellbardt S, Walzak H, Mldenhauer G, Krammer P: APO-1 (CD95)-dependent and -independent antigen receptor-induced apoptosis in human T and B cell lines. Int Immunol 7:1873, 1995
52. Hahne M, Renno T, Shroeter M, Irmler, French L, Bornand T, MacDonald HR, Tschopp J: Activated B cells express functional Fas ligand. Eur J Immunol 26:721, 1996
53. Brick-Ghannam C, Huang FL, Temine N, Charron D: Protein kinase C (PKC) activation via human leucocyte antigen class II molecules. J Biol Chem 266:24169, 1991
54. Rothstein TL, Wang JMK, Panka DJ, Foote LC, Wang Z, Stanger B, Cui H, Ju S, Marshak-Rothstein A: Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 374:164, 1995
55. Chaouchi N, Vasquez A, Galanaud P, Leprince C: B cell antigen receptor-mediated apoptosis: Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking. J Immunol 154:3096, 1995
56. Truman J-P, Choqueux C, Charron D, Mooney N: HLA class II molecule signal transduction leads to either apoptosis or activation via two different pathways. Cell Immunol 172:149, 1996